From the Journals

Postpartum depression screening in well-child care appears promising


 

FROM PEDIATRICS

Screening for postpartum depression at well-child visits improved both maternal depressive symptoms and overall mental health and parenting, according to results of a study from the Netherlands.

“This promising finding warrants wider implementation of screening for postpartum depression,” said Dr. Angarath I. Van der Zee-van den Berg of the University of Twente, Enschede, the Netherlands, and associates.

Doctor In Consultation With Depressed Female Patient monkeybusinessimages/Thinkstock
In a prospective study of mothers visiting Dutch well-child care centers after childbirth between Dec. 1, 2012, and April 1, 2014, they were exposed either to screening at 1, 3, and 6 months post partum (intervention condition) or to CAU (control condition).

Results showed significantly fewer mothers in the intervention group were depressed at 9 months post partum, compared with the CAU group (0.6% of 1,843 vs. 2.5% 1,246 for major depression), with an adjusted odds ratio of 0.28 (95% confidence interval, 0.12-0.63). The difference also was significant for minor and major depression, with 3.0% of the intervention group affected vs. 8.4% of the CAU group, and the adjusted odds ratio was 0.40 (95% confidence interval, 0.27-0.58). For parenting, anxiety symptoms, and mental health functioning, the intervention resulted in effect sizes ranging from 0.23 to 0.27.

“We found screening for postpartum depression to have a negligible effect on socioemotional development of the child with no former evidence to compare with,” Dr. Van der Zee-van den Berg and his associates said. “Attention for the mother-child interaction in the trajectory after screening may improve child outcomes; this evidently requires further study.”

To find out more information see Pediatrics (2017;140[4]:e20170110).

Recommended Reading

First trimester lithium exposure ups risk of cardiac malformations
MDedge ObGyn
OSA in pregnancy linked to congenital anomalies
MDedge ObGyn
All isn’t well with HIV-exposed uninfected infants
MDedge ObGyn
FDA has the resources to answer questions about medicines and pregnancy
MDedge ObGyn
Prenatal methadone maintenance linked to poorer child neurodevelopment
MDedge ObGyn
Early neuroimaging essential for Zika-exposed neonates
MDedge ObGyn
Extreme caffeine use in early pregnancy risks offspring behavioral disorders
MDedge ObGyn
Researchers identify ‘congenital NAD deficiency disorders’
MDedge ObGyn
Opening the door to gene editing?
MDedge ObGyn
Cerebral palsy rate down in children born very or moderately preterm
MDedge ObGyn